Loading...
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Tumor lysis syndrome (TLS) is a life-threatening emergency that usually develops in rapidly proliferating hematologic malignancies or advanced solid tumor following cytotoxic chemotherapy or therapeutic interventions. TLS is especially rare in patients with hepatocellular carcinoma (HCC). Therefore,...
Na minha lista:
| Udgivet i: | Case Rep Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443662/ https://ncbi.nlm.nih.gov/pubmed/32884512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508583 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|